Found on pharmacist.com
Group by:
Title Date Type
State of Washington made progress toward achieving program goals for enhancing its PDMP
HHS Office of Inspector General (04/15/19)
The HHS Office of Inspector General has identified actions that the state of Washington has taken, using federal funds for improving prescription drug monitoring programs (PDMPs), to achieve program goals toward improving safe prescribing practices and preventing prescription drug abuse and misuse…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
Bill aims to allow more flexibility for prescription drug spending
Beckley Register-Herald (WV) (04/17/19) Holdren, Wendy
The Restoring Access to Medication Act (RAMA) was recently introduced in the U.S. Senate and aims to reverse a provision in the Affordable Care Act (ACA) that limits the use of funds from pre-tax health accounts, allowing consumers to have more flexibility when purchasing prescription drugs or OTC…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
340B program may hinder access to costly drugs as hospitals exploit discounts: CRE
FierceHealthcare (04/19/19) Renfrow, Jacqueline
A report from the Center for Regulatory Effectiveness (CRE) suggests that the 340B drug discount program may affect patient access to costly drugs. CRE found that the number of uninsured, impoverished patients without access to medical care and dental care grew between 2009 and 2015, even as the…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
IBM stops development, sales of Watson for drug discovery
Becker's Hospital Review (04/18/19) Park, Andrea
Citing inadequate financial performance, IBM has discontinued the development and sales of its Watson for Drug Discovery product. IBM's Watson artificial intelligence (AI) software for this product was introduced in 2014, with the goal of helping pharmaceutical companies develop new drugs. Sanofi,…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
CMS rule aims to block use of drugmaker coupons on ACA plan members' out-of-pocket costs
Fierce Healthcare (04/18/19) Minemyer, Page
CMS on April 18 filed a new rule that includes a provision to allow insurers in the Affordable Care Act's (ACA) 2020 plan year to implement copay accumulator programs that would block the use of manufacturer coupons to lower annual out-of-pocket costs on certain brand name drugs when there is a…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
Measles in 2019 -- Going backward
New England Journal of Medicine (04/17/19) Paules, Catharine I.; Marston, Hilary D.; Fauci, Anthony S.
America's successful eradication of measles at the start of the century appears to be reversing, with CDC documenting at least 555 cases in 20 states so far this year. Immunization efforts were widely credited for the 2000 accomplishment, and the current series of localized outbreaks are blamed on…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
J&J's new ketamine-like depression drug off to 'very, very strong start,' company says
CNBC (04/16/19) LaVito, Angelica
As many as 800 health centers have been approved to administer esketamine (Spravato—Johnson & Johnson), a ketamine-like depression drug recently cleared by FDA. Esketamine is already being used by patients for treatment-resistant depression, the company says. The drug is similar to…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
Walgreens, SmileDirectClub partner on SmileShop pilot
Drug Store News (04/19/19) Salazar, David
Walgreens and SmileDirectClub are partnering to test SmileShops within four Walgreens stores in four markets. Under the pilot program, teeth-straightening solutions will be available in Walgreens locations in Tampa and Orlando, FL; Cleveland, OH; and Tempe, AZ. The SmileShops in Walgreens will…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
Two-wave U.S influenza season is now the longest in a decade
Associated Press (04/19/19) Stobbe, Mike
CDC reported Friday that the current influenza season has lasted for 21 weeks. While the influenza season initially seemed like it would be short and mild, a second viral wave has made it the longest in a decade. The season started around Thanksgiving with a more mild strain; however, in February,…
Apr 21, 2019 Publication Pharmacy Today Daily Edition
FDA permits marketing of first medical device for treatment of ADHD
FDA News Release (04/19/19)
The first medical device to treat ADHD received FDA approval on Friday. The Monarch external Trigeminal Nerve Stimulation (eTNS) System, a prescription-only device from NeuroSigma, is indicated for individuals aged 7–12 years who are not currently taking prescription ADHD medication. "This…
Apr 21, 2019 Publication Pharmacy Today Daily Edition